| INTRODUCTION
Pancreatitis in cats (FP) is thought to be underdiagnosed because of its nonspecific clinical signs and low sensitivities of available diagnostic tests. [1] [2] [3] With increased awareness, the advent of improved imaging technology and introduction of more sensitive laboratory tests, antemortem diagnosis of FP has increased. 2, 4 Owing to the nonspecific signs of acute (AP) and chronic (CP) pancreatitis, overlapping with those of many other diseases, the diagnosis of FP is based on compatible clinical signs and corroborative laboratory and imaging findings. 4, 5 Ultrasonographic changes in pancreatic echogenicity and size, increased peripancreatic echogenicity, free or peri-pancreatic abdominal fluid accumulation, and dilated pancreatic and bile ducts are suggestive of pancreatic inflammation. 4, [6] [7] [8] Concurrent increases in serum pancreatic lipase activity, including 1,2-o-dilauryl-rac-glycerol-glutaric acid-(6 0 -methylresorufin)-ester (DGGR) lipase or feline pancreatic lipase immunoreactivity (fPLI) are supportive of FP. 4, 5, 9, 10 These markers, although relatively specific for pancreatitis, often have unsatisfactory sensitivity. 4, 5 Three histologically distinct forms of FP are recognized, including acute necrotizing pancreatitis (ANP), acute suppurative pancreatitis (ASP) and CP. 1, 2, [11] [12] [13] Histologically, ANP and ASP cases may have concurrent fibrosis (a diagnostic criterion of CP 1 ), whereas ultrasonographically, proposed criteria of CP (eg, increased pancreatic echogenicity) and AP (eg, pancreatomegaly, hypoechoic pancreas, increased peripancreatic mesenteric echogenicity and fluid) are found in both forms of FP. 8, 11 The clinical ramifications of such distinctions are similarly unclear. Chronic pancreatitis is thought to be milder in clinical presentation, of longer duration, and may remain subclinical, as reflected by the high prevalence of pancreatic histologic lesions in apparently healthy cats. 1 Long-standing sequelae of CP include exocrine pancreatic insufficiency and diabetes mellitus (DM), 12 and CP often is associated with concurrent chronic inflammatory hepatobiliary and intestinal diseases. 1, 11, [14] [15] [16] Conversely, AP, specifically ASP, is associated with younger age of onset and worse prognosis. 13 However, AP and CP are often clinically indistinguishable, 11 sharing similar history, clinical, laboratory, and imaging findings. Furthermore, CP may present with acute "flare-ups" of the disease, mimicking AP, whereas recurrent AP episodes likely contribute to development of CP. 1, 12, 17 Several factors are implicated in FP, including prior general anesthesia, hypoperfusion, organophosphate intoxication, pancreatolithiasis, infection and trauma, but most cases are idiopathic. 2, 13, [17] [18] [19] [20] The consequences of AP may be devastating, as pancreatic zymogens are activated, and an inflammatory storm ensues. 12, 17 The deleterious effects of active pancreatic enzymes on cellular membranes, endothelium, adipose tissue, and the coagulation cascade can result in tissue damage, necrosis, disseminated intravascular coagulation (DIC), thrombosis, edema formation, and hypoxia. 12, 17, [21] [22] [23] The fatality rate of AP in cats ranges from 9% to 41%. [24] [25] [26] However, despite increased awareness and improved diagnostic capability, recent, largescale clinical studies of FP are scarce, hampering our understanding of its presentation and management. Some clinical studies were published >15 years ago, and others are limited in size (≤20 cases) or scope (ie, focusing on pancreatitis in cats with concurrent DM or inflammatory bowel disease [IBD] ). Therefore, we conducted a comprehensive retrospective study in a large heterogeneous cohort of cats with FP requiring hospitalization and investigated potential prognostic factors.
| MATERIALS AND METHODS

| Cats and definitions
Our study was conducted at a tertiary referral teaching hospital. (http://www.iris-kidney.com/pdf/grading-of-acute-kidney-injury.pdf).
Survivors were defined as alive at discharge, whereas nonsurvivors included cats that died or were euthanized during hospitalization because of deterioration, despite ongoing treatment. and used for microscopic evaluation of blood cells, including a manual platelet count, and for excluding platelet clumping as a cause for spurious thrombocytopenia. When platelet clumping was observed, the platelet count was excluded from statistical analyses. Differential leukocyte counts were only included when generated by the Advia analyzer after admission to the hospital. In 44 of the cats (28%), when the CBC had been performed by referring veterinarians within 24 hours of admission to the hospital, it was not repeated, and hematological data (excluding the differential leukocyte count) provided by the referring veterinarians were included in the study.
| Collection of samples and laboratory methods
| Statistical analyses
The (Table 3) . Frequency of increased serum creatinine concentration (>1.6 mg/dL) was higher (P = .014) in nonsurvivors (21/35 cats; 60%) compared to survivors (44/120, 36.7%). In nonsurvivors, the frequencies of hypoglycemia (4/32 cats; 12.5%) and ionized hypocalcemia (4/18 cats; 22.2%) were higher compared to survivors (2/112 cats;
1.8% and 3/66 cats; 4.5%, respectively; P = .007 and P = .016, respectively). Concurrent AKI was documented in only 1 of 7 cats with ionized hypocalcemia. When performed, PT and aPTT were prolonged in most cats, with no significant group differences (Table 3) .
Ultrasonographic findings consistent with pancreatitis were documented in 134 cats, including pancreatomegaly (109 cats; 81.3%) and decreased (42; 31.3%) or increased (20; 14.9%) pancreatic echogenicity. Extra-hepatic biliary dilatation, pancreatic duct dilatation, and increased peri-pancreatic echogenicity were noted in 32 (24%), 15 (11%) and 17 (13%) cats, respectively.
Comorbidities and complications were identified commonly, including hepatobiliary, renal, intestinal, endocrine, and cardiovascular diseases (Table 5 ). Pleural effusion (P = .003) was more frequently identified in nonsurvivors compared to survivors (Table 5 ). Persistent anorexia during hospitalization was a negative prognostic factor (survivors, 1/116; 0.9% vs nonsurvivors, 5/33; 15.2%; P = .001).
During hospitalization, parenteral nutrition (PN) was administered to 9 cats, of which 8 received only amino acid-containing products, and increased odds of death (P = .024 and P = .005, respectively).
| DISCUSSION
Pancreatitis in cats encompasses a heterogeneous group of histological entities, for which ante-mortem diagnosis is rarely achieved.
2 The occurrence of fever at presentation was unexpectedly more common in survivors. This finding potentially was related to the increased frequency of azotemia in nonsurvivors, which previously has been associated with hypothermia in cats, 33 and the increased frequency of fever in non-azotemic cats. The higher frequency of hypoglycemia and severe lethargy in the nonsurvivors is another possible explanation. Lastly, the occurrence of fever likely prompted antibacterial treatment in all hyperthermic cats, 2,31,34 which was associated with survival in our study.
Contrary to previous reports, leukopenia was not associated with death in our study. 2, 31 Neutrophil cytoplasmic toxicity, a common finding in ill hospitalized cats, 35 was documented in almost half of the cats, surpassing in frequency the occurrence of left shift, a reported negative prognostic marker in cats, 35 as well as that of leukocytosis, leukopenia, and neutrophilia.
Increased CK activity, albeit unassociated with survival, was noted frequently in our study. A marker of muscle injury, CK activity was associated with longer hospitalization time and death in a large heterogeneous cohort of ill cats, where pancreatitis constituted 8.5% of the cases, of which 45% had increased CK activity, and recently was associated with death in a study of 71 cats with hepatic lipidosis (HL), of which 24% had concurrent pancreatitis. 36, 37 In another study, CK activity was significantly higher in anorectic cats, and was deemed a useful nutritional status marker, 38 as in humans. 39 In our study, lethargy, likely associated with recumbency, anorexia, and weight loss were common and potentially accounted for the increased CK activity.
Previously unreported, higher frequencies of several serum biochemistry abnormalities were documented in nonsurvivors, including higher frequencies of azotemia, hypoglycemia, and low serum TCO 2 concentration. Because serum bicarbonate comprises >90% of serum TCO 2 , decreased TCO 2 often is indicative of acidemia and metabolic acidosis. 40, 41 Medical conditions resulting in hypoperfusion and anaerobic metabolism often lead to lactic acidosis, the most common cause of metabolic acidosis in cats. 42 Most cats in our study were dehydrated, and concurrent vomiting, diarrhea and anorexia might have resulted in hypovolemia and subsequent hypoperfusion. 42 Furthermore, concurrent hypoglycemia, diabetic ketoacidosis (DKA), and kidney disease, variably present in this cohort, possibly contributed to metabolic acidosis. 42 Although the prognostic relevance of metabolic acidosis is contingent upon its cause and reversibility, 42, 43 its association with death in our study likely mirrors disease severity and comorbidities, and also was reported in cats with DKA and in dogs with pancreatitis. 44, 45 Accurate characterization of acid-base abnormalities would have necessitated venous blood gas and lactate measurements, which were unavailable in most cats. Future studies, with serial monitoring of acid-base status during hospitalization, may further elucidate the prognostic and therapeutic implications of these findings. Ionized hypocalcemia was more frequent in nonsurvivors compared to survivors, in accordance with previous findings. 24, 46 A known complication of both AKI and AP, it might have contributed to the increased frequency of lethargy in nonsurvivors, and contributed to seizures in 1 cat.
Azotemia was more frequent in nonsurvivors. Pancreatitis and AKI are common comorbidities in humans and dogs, each can potentially precipitate the other. [47] [48] [49] Azotemia at presentation and development of AKI also are associated with worse prognosis in other diseases of cats, 44, 50 especially as AKI itself carries a guarded prognosis. 51 Hypoglycemia occurs in cats with AP and CP, 11 and was reported previously in 3/4 ASP cases. 13 Its high frequency, particularly in AP and ASP, may account for its higher frequency in nonsurvivors and its association is impaired, predisposing to insulin-induced hypoglycemic crises. 52, 53 Diabetic cats with ANP show a marked response to insulin administration. 13 Inadequate pancreatic glucagon secretion also may account for pancreatitis-induced hypoglycemia in cats, warranting further studies.
Clotting times (PT and aPTT), measured in only 33 cats, were almost invariably prolonged. Hemostatic derangements in FP are poorly defined. In 1 study, median clotting times were within RI in both ANP and CP, 11 whereas in another, both were prolonged in all cats with concurrent HL and AP, but only in 2/6 HL cases in which concurrent AP was absent. 54 In a study of DIC in cats, FP accounted for 12/46 cases. 23 Overt bleeding was not observed in any of the cats in our study, despite the high frequency of hemostatic abnormalities.
Evidence-based treatment recommendations for FP are lacking.
Treatment guidelines largely rely on experience in human patients, circumstantial evidence and expert opinion. 2, 31 We have identified 2 salient treatment-related variables that differed between the 2 outcome groups. First, PN was more commonly administered in nonsurvivors, whether as sole nutritional support or as ancillary treatment to enteral feeding. It is impossible to retrospectively determine whether PN treatment merely reflects a selection bias associated with more severe and prolonged disease (ie, PN was administered to cats too unstable to undergo general anesthesia for feeding tube placement or cats with persistent anorexia during hospitalization), or independently imparts a worse prognosis. In a retrospective study of TPN in cats, of which 46%
had pancreatitis, the mortality rate was 52%. 32 In humans with AP, withholding food is no longer recommended, and PN alone has been shown to compromise intestinal barrier integrity, increasing the risk of bacterial translocation and promoting mucosal atrophy and proinflammatory responses. 32, 55 In our study, multivariable logistic regression showed that failure to eat voluntarily during hospitalization was a significant risk factor for death. Ultimately, the sequelae of PN increase morbidity and mortality, possibly accounting for our findings. Second, antibiotic treatment was more commonly withheld in nonsurvivors compared to survivors. Scientific reviews of FP espouse the notion that antibacterial treatment should be reserved for severe cases, such as those presenting with shock, fever, marked leukocytosis, or pancreatic abscessation. 2, 31, 34 This notion is based on experimental FP models, histological and molecular findings suggestive of bacterial involvement, and drawing parallels between cats and humans with pancreatitis. In a series of studies in cats, experimentally-induced pancreatitis enhanced colon-derived Escherichia coli pancreatic colonization, and facilitated pancreatic colonization by exogenous E. coli, administered by IV, transcolonic, or pancreatic ductular routes. 56, 57 The latter was prevented by prophylactic cefotaxime administration. 58 Florescence in situ hybridization has identified bacteria in 35% of pancreatic samples from cats with moderate to severe pancreatitis, but in only 1 healthy control cat (Simpson and coworkers.
Culture-independent detection of bacteria in feline pancreatitis. In: 21st ACVIM Forum, Denver, Colorado, June 15-18, 2011). Employing a similar method, intrahepatic bacteria were noted in 41% of cats with inflammatory liver disease, 59 which is clinically relevant, because hepatic and pancreatic inflammations are common comorbidities in cats, because their collecting ducts join anatomically before entering the duodenum. 12, 18, 31 Moreover, pancreatic intra-ductular neutrophilic inflammation and presence of bacteria, albeit rarely reported, are suggestive of ascending infection in some cases, 1, 13 in addition to suspected hematogenous spread in inflammatory hepato-billiary diseases. 59 Secondary bacterial infection is a common cause of morbidity and mortality in humans with AP. 55 Prophylactic antibiotic treatment, however, is controversial, with conflicting data to support this practice. 55 Prospective randomized studies are warranted to clarify the role of antibiotic treatment in FP, particularly in light of the limited number of cats in our study in which antibiotic treatment was withheld.
Published mortality rates in FP are scarce, and vary widely among studies, [24] [25] [26] owing to the paucity of observational studies and wide heterogeneity in etiology and histopathological classification, as well as the variable occurrence of comorbidities. 14, 16, 18, 54, 60 In our study, without distinction between AP and CP, the overall mortality rate was approximately 22%.
Our study had several limitations. First, data were retrospectively retrieved, and medical records occasionally were incomplete, thereby weakening some statistical analyses, which also were hampered when small groups were compared. Certain laboratory tests (ie, hemostatic tests) were available only in a small number of cats.
Second, owing to study design, bias may have decreased the validity of some findings, such as the association between PN and outcome, and a cause and effect relationship cannot be necessarily insignificant, despite the relatively large cohort. However, as stated above, our study was an exploratory one, and had no pre-specified hypotheses, in which large amount of data with multiple comparisons were analyzed. The use of multiplicity adjustment in such studies engenders loss of power, and substantially increases the type II error rate, while eliminating the chances of type I errors. 61 Thus, many factors of potential clinical relevance may have been overlooked. We therefore elected to present our exploratory results, which must be subsequently tested in confirmatory, hypothesis-driven studies. 61 Third, in some cats, pancreatitis was diagnosed by ultrasonography, along with compatible clinical and laboratory findings, whereas in other cats, histopathology or pancreatic-specific lipases were used. IQR, interquartile range; SD, standard deviation. a Normally and non-normally distributed variables are presented as mean (SD) or median (IQR), respectively. For each variable, the number (%) of cases above and below reference interval are also presented. b Comparisons of quantitative variables between survivors and nonsurvivors. When the Bonferroni method was employed for correcting for the significance level for 144 comparisons made in this study, the adjusted significance level was .00034, rendering all results statistically insignificant. c The frequencies of cats within, above and below reference intervals were compared between groups by the χ 2 or the Fisher exact tests, and when significant, post hoc pair-wise analyses were made to determine which frequency was significantly different.
Admittedly, a definitive diagnosis of FP is not commonly achieved, because procurement of biopsy samples for histopathology is seldom carried out in most clinical settings. 2, 31 Although abdominal sonography lacks sensitivity (ranging from 11% to 84%, depending on disease severity, ultrasound technology and the radiologist's expertise), it is fairly specific for diagnosing pancreatitis. 2, [6] [7] [8] 19, 28, 31 Moreover, when the accuracy of sonography for detecting pancreatitis is assessed against pancreatic-specific lipase assays, specificity may spuriously decrease, because these assays are relatively insensitive in mild to moderate disease. 5, 7 Therefore, despite its inherent limitations, ultrasonographically-confirmed cases are commonly recruited. 2, 24, 26, 62 In addition, 16 cats were diagnosed by positive SNAP fPLI, which indicates both equivocal (3.6-5.3 μg/L) and true positive (>5.3 μg/L) cases, 4 and therefore the proportion of false positives in this group could not be determined in the absence of further investigations.
Moreover, in this subgroup of cats, the proportion of nonsurvivors was significantly higher (8/16 cats), which may have led to spurious overestimation of the overall nonsurvivor rate.
Fourth, for some cases the occurrence of co-morbidities (eg, IBD, cholangiohepatitis) could not have been excluded without histopathology, which was unavailable in most cases.
Finally, our study was conducted in a single, tertiary veterinary teaching hospital, and its results should be applied cautiously to other clinical settings.
In conclusion, several important variables, of clinical and therapeutic relevance (eg, hypoglycemia, ionized hypocalcemia, azotemia, antibacterial use and PN) were identified that differed between survivors and nonsurvivors in cats with AP. Prospective, controlled studies are required to examine the validity of these findings. 
